147419-93-0

147419-93-0 structure

Name: Ginsenoside Rg6
Chemical Name: (3β,6α,12β,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl 2-O-(6- deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
CAS Number: 147419-93-0
Molecular Formula: C₄₂H₇₀O₁₂
Molecular Weight: 766.998
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2018-09-11 10:35:24
Modify Date: 2024-01-04 22:06:43
Ginsenoside Rg6 is the component isolated from notoginseng. Ginsenoside Rg6 inhibits TNF-α-induced NF-κB transcriptional activity with an IC50 of 29.34±2.22 μM in HepG2 cells. Ginsenoside Rg6 also exhibits apoptosis-inducing effect.

Name	(3β,6α,12β,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl 2-O-(6- deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
Synonyms	β-D-Glucopyranoside, (3β,6α,12β)-3,12-dihydroxydammara-20,24-dien-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)- (3β,6α,12β)-3,12-Dihydroxydammara-20,24-dien-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside Ginsenoside Rg6

Description	Ginsenoside Rg6 is the component isolated from notoginseng. Ginsenoside Rg6 inhibits TNF-α-induced NF-κB transcriptional activity with an IC50 of 29.34±2.22 μM in HepG2 cells. Ginsenoside Rg6 also exhibits apoptosis-inducing effect.
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Natural Products >> Terpenoids and Glycosides Research Areas >> Inflammation/Immunology
Target	NF-κB:25.12 μM (IC50, in SK-Hep1 cell) NF-κB:29.34 μM (IC50, in HepG2 cell) Apoptosis
In Vitro	Ginsenoside Rg6 inhibits TNF-α-induced NF-κB transcriptional activity with an IC50 of 25.12±1.04 μM in SK-Hep1 cells, consistent with the data from HepG2 cells[1]. Ginsenoside Rg6 exhibits obvious anti-proliferative and apoptosis-inducing effects when it is applied to JK cells in vitro. Ginsenoside Rg6 blocks S arrest in the cell cycle. CCK-8 method shows that after Ginsenoside Rg6 is used, several groups with different concentrations obviously inhibits JK cell proliferation in human lymphocytoma, with evident dose dependency. Based on IC50, the median inhibitory concentration of Ginsenoside Rg6 is 83.08 μM[2].
Cell Assay	HepG2 and SK-Hep1 cells are maintained in Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated fetal bovine serum, 100 units/mL Penicillin, and 10 μg/mL Streptomycin, at 37°C and 5% CO2. Cell-Counting Kit (CCK)-8is used to analyze the effect of compounds (e.g., Ginsenoside Rg6; 0.01, 0.1, 1 and 10 μM) on cell toxicity. Cells are cultured overnight in 96-well plate (~1×104 cells/well). Cell toxicity is assessed after the addition of compounds on dose-dependent manner. After 24 h of treatment, 10 μL of the CCK-8 solution is added to triplicate wells, and incubated for 1 h. Absorbance is measured at 450 nm to determine viable cell numbers in wells[1].
References	[1]. Cho K, et al. Inhibition of TNF-α-Mediated NF-κB Transcriptional Activity by Dammarane-Type Ginsenosidesfrom Steamed Flower Buds of Panax ginseng in HepG2 and SK-Hep1 Cells. Biomol Ther (Seoul). 2014 Jan;22(1):55-61. [2]. Chen B, et al. Apoptosis-inducing effect of ginsenoside Rg6 on human lymphocytoma JK cells. Molecules. 2013 Jul 9;18(7):8109-19.

Density	1.3±0.1 g/cm3
Boiling Point	850.6±65.0 °C at 760 mmHg
Molecular Formula	C₄₂H₇₀O₁₂
Molecular Weight	766.998
Flash Point	468.2±34.3 °C
Exact Mass	766.486755
PSA	198.76000
LogP	8.20
Vapour Pressure	0.0±0.6 mmHg at 25°C
Index of Refraction	1.589
Storage condition	2-8℃

RIDADR	NONH for all modes of transport

147419-93-0	439858-23-8
63223-86-9	364779-15-7
123617-34-5	11019-45-7
62025-50-7	105558-26-7
53963-43-2	1346522-90-4